BEIJING JINGKE SHENGYUAN BIOTECHNOLOGY CO LTD
Overview
BEIJING JINGKE SHENGYUAN BIOTECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering FRESH NK CELL ACTIVATION AND EXPANSION KIT; MESENCHYMAL STEM CELL SERUM-FREE MEDIUM (WITH SUPPLEMENTS).
API / Drug Master Files
BEIJING JINGKE SHENGYUAN BIOTECHNOLOGY CO LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- MESENCHYMAL STEM CELL SERUM-FREE MEDIUM (WITH SUPPLEMENTS)Active2025-06-09
- FRESH NK CELL ACTIVATION AND EXPANSION KITActive2025-06-09
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to BEIJING JINGKE SHENGYUAN BIOTECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this BEIJING JINGKE SHENGYUAN BIOTECHNOLOGY CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.